Family offices ramp up deal-making in June with bets on biotech
For investment firms of the ultra-wealthy, deal-making is heating up. In June, family offices made 60 direct investments in companies, ending three straight months of declining deal activity, according to data provided exclusively to CNBC by Fintrx. June’s tally is an improvement over the 47 deals recorded in May, though…
Continue Reading
Subscribe to unlock the full article and access premium financial content.
Click here to read the full story: CNBC

